RNA Latest Press Releases

-- October 27, 2026 --

Atrium Therapeutics Doses First Patient in Corventis , the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome PRNewswire 6:30 AM

-- October 20, 2026 --

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PRNewswire 5:24 PM

Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing PRNewswire 8:10 AM

-- October 8, 2026 --

Atrium Therapeutics Announces $50 Million Private Placement PRNewswire 6:31 AM

-- September 21, 2026 --

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:30 PM

-- September 2, 2026 --

Atrium Therapeutics to Participate in Upcoming Investor Conferences PRNewswire 8:01 AM

-- August 20, 2026 --

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 6:24 PM

-- August 13, 2026 --

Atrium Therapeutics Reports Second Quarter 2026 Financial Results PRNewswire 4:46 PM

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration PRNewswire 8:00 AM

-- July 20, 2026 --

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PRNewswire 5:59 PM

-- July 14, 2026 --

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome PRNewswire 6:30 AM

-- June 23, 2026 --

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:05 PM

Market Data Delayed 15 Minutes